Close
FINDING CURES TOGETHER<sup>SM</sup>

TME Election Results

Congratulations to Theresa A. Guise, MD, TME Chairperson-elect 2019-2020

Our thanks to Theresa A. Guise, MD, and Jeffrey W. Pollard, PhD, for standing for election, and to the TME membership for participating in the election. We congratulate Dr. Guise on being elected as TME chairperson-elect. Dr. Guise will assume the office of chairperson-elect at the AACR Annual Meeting 2019, March 29-April 3, in Atlanta, Georgia.

Theresa A. Guise, MD
Jerry W. and Peg S. Throgmartin Professor of Oncology,
 Professor of Medicine and Pharmacology
Department of Medicine, Division of Endocrinology;
Department of Pharmacology
Indiana University School of Medicine
Indianapolis, Indiana, USA

Other Positions Currently Held
Co-Leader, Tumor Microenvironment, Indiana University Simon Cancer Center, 2010-Present
Member, Board of Directors, Cancer and Bone Society, 2015-Present

Education:
1985
MD, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Research Interests/Vision Statement:
General research interests of the Guise lab include the study of cancer and cancer treatment on the bone microenvironment, musculoskeletal heath and metabolism using a multidisciplinary “bench-to-bedside-and-back” approach. Specific interests include: 1) the molecular mechanisms of bone metastasis; 2) the role of the bone microenvironment on tumor progression, muscle dysfunction and metabolic abnormalities; 3) development of treatment modalities to prevent cancer metastases and improve musculoskeletal health; and 4) the role oxidative stress on cognitive function associated with cancer and cancer treatment.

My vision as Chairperson-elect, in collaboration with the AACR leadership and the TME membership, includes:
1. Promote the latest advances in the field of the tumor microenvironment (TME) across AACR membership with the TME Steering Committee through TME-focused sessions at the Annual Meeting as well as via the AACR Special Conference on the Tumor Microenvironment. These sessions will highlight the most exciting science in TME biology as well as technology to study this biology.
2. Recruit and retain young and minority investigators to study TME and promote diversity.
3. Partner with basic, clinical and patient advocacy organizations (local, national and international) with a specific interest in TME.
4.Emphasize the need to validate basic and translational science using microenvironment-specific human tissues and find better ways to make these materials available to TME investigators.

Thank you for your confidence in me to achieve our goals together!